Publications by authors named "James Liebmann"

Claim this Profile
I
Immunohistochemical expression and prognostic value of PD-L1 in Extrapulmonary small cell carcinoma: a single institution experience.
Mohammed Salhab, Yazan Migdady, Melanie Donahue, Yiqin Xiong, Karen Dresser, James Liebmann

J Immunother Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiological measurements corroborate symptomatic improvement after therapeutic leukapheresis in a pregnant woman with chronic myelogenous leukemia.
Pallavi Galera, Stefanie Haynes, Paula Sulmasy, Jeffrey A Bailey, Mindy Greene, James Liebmann

J Clin Apher· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnostic utility of tumor markers: a teachable moment.
Justin K Lui, Adedotun A Ogunsua, Steven C Hatch, James Liebmann, Gail Scully

Am J Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pixantrone dimaleate in combination with fludarabine, dexamethasone, and rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: phase 1 study with a dose-expansion cohort.
Tomasz P Srokowski, James E Liebmann, Manuel R Modiano, Gary I Cohen, Barbara Pro

Cancer· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine plus 3-weekly irinotecan (XELIRI regimen) as first-line chemotherapy for metastatic colorectal cancer: phase II trial results.
Yehuda Z Patt, Fa-Chyi Lee, James E Liebmann, Dimitrios Diamandidis, S Gail Eckhardt

Am J Clin Oncol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COX-2 inhibitors as cancer treatment: will they be the new warfarin or trastuzumab?
James Liebmann

Cancer Invest· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial.
Christina A Meyers, Jennifer A Smith, Andrea Bezjak, Minesh P Mehta, James Liebmann

J Clin Oncol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy in women with breast cancer.
James Liebmann, Clark Haskins, Barbara McAneny, Richard Giudice, Douglas Clark

Ann Intern Med· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis